NDC 67877-177 – Olanzapine
Olanzapine 20 mg/1 · Tablet · Oral
Product NDC67877-177
Product details
- Brand name
- Olanzapine
- Generic name
- Olanzapine
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA202295
- Marketed since
- January 1, 2012
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Olanzapine 20 mg/1
Package NDC codes (6)
| Package NDC | Description | Since |
|---|---|---|
| 67877-177-01 | 100 TABLET in 1 BOTTLE (67877-177-01) | Jan 1, 2012 |
| 67877-177-10 | 1000 TABLET in 1 BOTTLE (67877-177-10) | Jan 1, 2012 |
| 67877-177-30 | 30 TABLET in 1 BOTTLE (67877-177-30) | Jan 1, 2012 |
| 67877-177-35 | 10 BLISTER PACK in 1 CARTON (67877-177-35) / 10 TABLET in 1 BLISTER PACK (67877-177-33) | Jan 1, 2012 |
| 67877-177-37 | 7 TABLET in 1 BOTTLE (67877-177-37) | Jan 1, 2012 |
| 67877-177-85 | 3 BLISTER PACK in 1 CARTON (67877-177-85) / 10 TABLET in 1 BLISTER PACK (67877-177-33) | Jan 1, 2012 |
Other Olanzapine products
- 68084-525 Olanzapine 2.5 mg/1 · Tablet, Film Coated · American Health Packaging
- 68084-528 Olanzapine 15 mg/1 · Tablet, Film Coated · American Health Packaging
- 68084-740 Olanzapine 10 mg/1 · Tablet, Film Coated · American Health Packaging
- 68084-723 Olanzapine 5 mg/1 · Tablet, Film Coated · American Health Packaging
- 68084-529 Olanzapine 20 mg/1 · Tablet, Film Coated · American Health Packaging
- 0517-0955 Olanzapine 10 mg/2mL · Injection, Powder, Lyophilized, For Solution · American Regent, Inc.
- 83854-003 Olanzapine 10 mg/2mL · Injection, Powder, Lyophilized, For Solution · Anthea Pharma Private Limited
- 71610-419 Olanzapine 15 mg/1 · Tablet, Film Coated · Aphena Pharma Solutions - Tennessee, LLC
- 60505-3140 Olanzapine 20 mg/1 · Tablet, Film Coated · Apotex Corp.
- 60505-3278 Olanzapine 20 mg/1 · Tablet, Orally Disintegrating · Apotex Corp.
- 60505-3110 Olanzapine 2.5 mg/1 · Tablet, Film Coated · Apotex Corp.
- 60505-3113 Olanzapine 10 mg/1 · Tablet, Film Coated · Apotex Corp.